Navigation Links
Renowned Operations and Supply Chain Expert Dr. David Simchi-Levi Joins OPS Rules

Waltham, Massachusetts (PRWEB) July 02, 2012

OpsRules Partners, LLC., a leading operations strategy consulting firm, today announced that Dr. David Simchi-Levi, world renowned supply chain expert, has joined the company as chairman.

Dr. David Simchi-Levi is an Engineering Systems professor at MIT and the co-founder of LogicTools, a supply chain software company that is now part of IBM. He has extensive experience both on the academic and the business sides of operations and supply chain management and is considered a leader in these fields.

His most recent book “Operations Rules: Delivering customer value through flexible operations” has been praised by business executives. The book addresses the current business concerns around Complexity Management, Flexibility, Segmentation and Supply Chain Risk Management. Dr. Simchi-Levi identifies the crucial element in a company's success: the link between the values it provides its customers and its operations strategies. Most importantly, he offers a set of scientifically and empirically-based rules that management can follow to achieve a quantum leap in operations performance.

Indeed, Professor Simchi-Levi's recent work with companies such as Cisco, Dell Computers and Pepsi Beverage Company, to name a few, underscores the impact of effective implementation of concepts such as supply chain flexibility, segmentation and complexity reduction on the firm's bottom line.

“There are many opportunities to achieve improved performance through better understanding of the basic drivers of operations” stated Dr. Simchi-Levi “I am excited to join OPS Rules and implement the many concepts and ideas that I have developed over many years. The opportunity to work with a team of professionals in order to delve into a company’s specific challenges, analyze its data and come up with innovative solutions that help it thrive is what drives me to start this new endeavor.”

Mike Romeri, OPS Rules Managing Partner observed “We are delighted that Dr. Simchi-Levi is joining us. Together we can achieve transformational thinking and develop intellectual property that enables and drives significant changes in strategy to improve customer value and reduce operational costs and risk.”

About OPS Rules
OPS Rules is a leading operations strategy consulting company with capable partners and associates who provide expertise, distinctive viewpoints and reputation for developing and implementing new ideas with leading companies. We take an analytical approach that is fact-based and data-driven that leads to recommendations and innovations that are followed through to successful implementations. We employ a flexible transformation approach that ensures successful adoption of essential new skills.

Contact: press(at)opsrules(dot)com or (855)677-7853

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
2. Amarillo Biosciences Announces Plan to Open Asia Operations Center in Taipei, Taiwan
3. NanoLogix Provides Testing and Operations Update
4. Hospira Names John B. Elliot Senior Vice President of Operations
5. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
6. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
7. Vermillion Sharpens Focus and Streamlines Operations in 2012
8. StemCyte Adds World Class Talent to its North America and Global Operations
9. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
10. inVentiv Health Selected to Provide Sales Operations Support for Santarus
11. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
Breaking Biology Technology:
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):